Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Robak, MaryAnn T.
90  Ergebnisse:
Personensuche X
?
1

The Undergraduate Teacher-Scholar Program: Comparing Near-P..:

Bourne, Sara M. ; Limfat, Sean ; Dilip, Sneha...
Journal of College Science Teaching.  50 (2021)  5 - p. 10-17 , 2021
Link: https://www.jstor.org/st..
 
?
2

Enantio- and diastereoselective addition of thioacetic acid..:

Kimmel, Kyle L. ; Robak, MaryAnn T. ; Thomas, Stephen..
Tetrahedron.  68 (2012)  12 - p. 2704-2712 , 2012
Link: https://doi.org/10.1016/..
 
?
3

Development of an N-sulfinyl prolinamide for the asymmetric..:

Robak, MaryAnn T. ; Herbage, Melissa A. ; Ellman, Jonathan A.
Tetrahedron.  67 (2011)  24 - p. 4412-4416 , 2011
Link: https://doi.org/10.1016/..
 
?
4

Synthesis and Applications of tert-Butanesulfinamide:

Robak, MaryAnn T. ; Herbage, Melissa A. ; Ellman, Jonathan A.
Chemical Reviews.  110 (2010)  6 - p. 3600-3740 , 2010
Link: https://doi.org/10.1021/..
 
?
5

Enantioselective Addition of Thioacetic Acid to Nitroalkene..:

Kimmel, Kyle L. ; Robak, MaryAnn T. ; Ellman, Jonathan A.
Journal of the American Chemical Society.  131 (2009)  25 - p. 8754-8755 , 2009
Link: https://doi.org/10.1021/..
 
?
6

Enantioselective Aza-Henry Reaction with an N-Sulfinyl Urea..:

Robak, MaryAnn T. ; Trincado, Monica ; Ellman, Jonathan A.
Journal of the American Chemical Society.  129 (2007)  49 - p. 15110-15111 , 2007
Link: https://doi.org/10.1021/..
 
?
7

Characterization of Mechanisms of Resistance in Previously ..:

Woyach, J. A. ; Jones, D. ; Jurczak, W....
Hematological Oncology.  41 (2023)  S2 - p. 249-250 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Safety and Efficacy of Acalabrutinib, Bendamustine, and Rit..:

Phillips, T. ; Wang, M. ; Robak, T....
Hematological Oncology.  41 (2023)  S2 - p. 586-587 , 2023
Link: https://doi.org/10.1002/..
 
?
9

PB1348 Thrombopoietin Receptor Agonist and Rituximab Combin..:

Witkowski, M. ; Ryzewska, W. ; Robak, T.
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101441 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Zanubrutinib safety/tolerability profile and comparison wit..:

Brown, J. R. ; Eichorst, B. ; Ghia, P....
Hematological Oncology.  41 (2023)  S2 - p. 459-461 , 2023
Link: https://doi.org/10.1002/..
 
?
11

MURANO: Final 7 year follow up and retreatment analysis in ..:

Kater, A. P. ; Harrup, R. ; Kipps, T. J....
Hematological Oncology.  41 (2023)  S2 - p. 239-242 , 2023
Link: https://doi.org/10.1002/..
 
?
12

P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERAT..:

Le Gouill, S. ; Długosz-Danecka, M. ; Rule, S....
HemaSphere.  6 (2022)  - p. 1021-1022 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P662: PATIENT-REPORTED OUTCOMES FROM A PHASE 3 RANDOMIZED S..:

Ghia, P. ; Barnes, G. ; Yang, K....
HemaSphere.  6 (2022)  - p. 560-561 , 2022
Link: https://doi.org/10.1097/..
 
?
14

P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EAR..:

Puła, A. ; Robak, P. ; Jarych, D....
HemaSphere.  6 (2022)  - p. 761-762 , 2022
Link: https://doi.org/10.1097/..
 
?
15

S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LEN..:

Dytfeld, D. ; Wróbel, T. ; Jamroziak, K....
HemaSphere.  6 (2022)  - p. 76-77 , 2022
Link: https://doi.org/10.1097/..
 
1-15